IL87193A0 - Baculovirus(acnpv)-insect cell expression system for ricin toxin proteins and muteins thereof having reduced galactose binding activity - Google Patents

Baculovirus(acnpv)-insect cell expression system for ricin toxin proteins and muteins thereof having reduced galactose binding activity

Info

Publication number
IL87193A0
IL87193A0 IL87193A IL8719388A IL87193A0 IL 87193 A0 IL87193 A0 IL 87193A0 IL 87193 A IL87193 A IL 87193A IL 8719388 A IL8719388 A IL 8719388A IL 87193 A0 IL87193 A0 IL 87193A0
Authority
IL
Israel
Prior art keywords
acnpv
muteins
baculovirus
binding activity
expression system
Prior art date
Application number
IL87193A
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of IL87193A0 publication Critical patent/IL87193A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL87193A 1987-07-24 1988-07-22 Baculovirus(acnpv)-insect cell expression system for ricin toxin proteins and muteins thereof having reduced galactose binding activity IL87193A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7712687A 1987-07-24 1987-07-24
US15377888A 1988-02-08 1988-02-08

Publications (1)

Publication Number Publication Date
IL87193A0 true IL87193A0 (en) 1988-12-30

Family

ID=26758913

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87193A IL87193A0 (en) 1987-07-24 1988-07-22 Baculovirus(acnpv)-insect cell expression system for ricin toxin proteins and muteins thereof having reduced galactose binding activity

Country Status (3)

Country Link
AU (1) AU2136788A (en)
IL (1) IL87193A0 (en)
WO (1) WO1989001037A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631974B1 (en) * 1988-05-31 1992-12-11 Agronomique Inst Nat Rech MODIFIED BACULOVIRUS, ITS PREPARATION METHOD AND ITS APPLICATION AS A GENE EXPRESSION VECTOR
DE69734656T2 (en) * 1996-04-30 2006-08-10 Twinstrand Therapeutics Inc., Burnaby ANTIVIRAL VARIANT OF RICIN PROTEINS
KR19980043226A (en) * 1996-12-02 1998-09-05 박영설 Heelless shoe sole with air bag
AU5003597A (en) * 1996-10-28 1998-05-22 Medical University Of South Carolina Methods and compositions for ricin fusion protein immunotoxins to treat cancer and autoimmune disease
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
KR101699142B1 (en) 2004-06-18 2017-01-23 암브룩스, 인코포레이티드 Novel antigen-binding polypeptides and their uses
SG158148A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
JP2008525473A (en) 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド Modified human growth hormone
MX2007007591A (en) 2004-12-22 2007-07-25 Ambrx Inc Methods for expression and purification of recombinant human growth hormone.
CA2590429C (en) 2004-12-22 2014-10-07 Ambrx, Inc. Compositions of aminoacyl-trna synthetase and uses thereof
CN103520735B (en) 2004-12-22 2015-11-25 Ambrx公司 Comprise non-naturally encoded amino acid whose formulations of human growth hormone
JP2008541769A (en) 2005-06-03 2008-11-27 アンブレツクス・インコーポレイテツド Improved human interferon molecules and their use
PT2339014E (en) 2005-11-16 2015-10-13 Ambrx Inc Methods and compositions comprising non-natural amino acids
WO2008030613A2 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Hybrid suppressor trna for vertebrate cells
ES2465473T3 (en) 2006-09-08 2014-06-05 Ambrx, Inc. Transcription of arnt suppressor in vertebrate cells
KR20090060294A (en) 2006-09-08 2009-06-11 암브룩스, 인코포레이티드 Modified human plasma polypeptide or fc scaffolds and their uses
CN104163864B (en) 2007-03-30 2017-08-01 Ambrx公司 Through modifying the polypeptides of FGF 21 and its purposes
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
JP5547083B2 (en) 2007-11-20 2014-07-09 アンブルックス，インコーポレイテッド Modified insulin polypeptides and their use
CN103694337B (en) 2008-02-08 2016-03-02 Ambrx公司 Modified leptin polypeptide and its purposes
UA118536C2 (en) 2008-07-23 2019-02-11 Амбркс, Інк. MODIFIED Bovine granulocyte colony-stimulating factor polypeptide and its application
NZ607477A (en) 2008-09-26 2014-09-26 Ambrx Inc Non-natural amino acid replication-dependent microorganisms and vaccines
KR101647164B1 (en) 2008-09-26 2016-08-09 암브룩스, 인코포레이티드 Modified animal erythropoietin polypeptides and their uses
CN107056929A (en) 2009-12-21 2017-08-18 Ambrx 公司 Porcine somatotropin polypeptide and its purposes by modification
CN107674121A (en) 2009-12-21 2018-02-09 Ambrx 公司 Bovine somatotropin polypeptide and its purposes by modification
MX346786B (en) 2010-08-17 2017-03-31 Ambrx Inc Modified relaxin polypeptides and their uses.
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
AR083006A1 (en) 2010-09-23 2013-01-23 Lilly Co Eli FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME
PL3412302T3 (en) 2014-10-24 2021-11-02 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
CN110637027B (en) 2017-02-08 2024-08-30 百时美施贵宝公司 Modified relaxin polypeptides comprising pharmacokinetic enhancers and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127839B1 (en) * 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
JP2521657B2 (en) * 1983-07-15 1996-08-07 インペリアル・ケミカル・インダストリーズ・ピーエルシー Recombinant DNA molecule and transformed host cell containing the same

Also Published As

Publication number Publication date
AU2136788A (en) 1989-03-01
WO1989001037A1 (en) 1989-02-09

Similar Documents

Publication Publication Date Title
IL87193A0 (en) Baculovirus(acnpv)-insect cell expression system for ricin toxin proteins and muteins thereof having reduced galactose binding activity
GB2198350B (en) Anti-acne pharmaceutical and cosmetic composition
GB8404280D0 (en) Biological preparations
AU8054187A (en) Nor-statine and nor-cyclostatine polypeptides
AU578973B2 (en) Improved cobalt catalysts and use thereof
JPS6460373A (en) Human cells and trioner, antibody and trasformer derived from said cells
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
AU7949787A (en) Strip feeding and control system
NZ222981A (en) 2'-deoxy-2'2'-difluoronucleosides, antibody conjugates and pharmaceuticals containing the conjugates
GB8421706D0 (en) Pharmaceutical preparations
NZ220441A (en) Unca-hydrazide-immunoglobulin (glyoprotein) conjugates and pharmaceutical composition
AU6081690A (en) Pyridazinones having cardiotonic and beta block activity
ZA887480B (en) Anti-coleopteran toxin and gene
HK63795A (en) Antibiotic polypeptide, process for its preparation and its use
AU4866185A (en) Specific binding materials, their preparations and use
GB8428201D0 (en) Biological preparations
AU581445B2 (en) N-arylsulfonyl-N'-triazinylureas and N-arylsulfonyl-N'- pyrimidinylureas
KR950000983B1 (en) ANTIBIOTIC LL-E19020 Ñß AND ÑÔ
AU590731B2 (en) Estriol-3-sulfate protein conjugates and antibodies thereto
GB8520189D0 (en) Pharmaceutical preparations
ZA852279B (en) Pharmaceutical preparations
GB2169902B (en) Polypeptide possessing cyclomaltodextrin glucanotransferase activity
ZA874729B (en) Antibiotic ll-e19020 alpha and beta
GB8506388D0 (en) Pharmaceutical preparations
SG127294G (en) Antibiotic polypeptide process for its preparation and its use